Flexible Assembly and Packaging Approach for Steering Combination Products Through Clinical Trials

The substantial increase in drug molecules utilizing combination product route to market has led to greater demand for contract manufacturers to support clinical builds (device manufacturing, drug/device assembly, packaging, kitting, and testing) of the combination product. This session will introduce how pharmaceutical/biotech companies can effectively partner with CDMOs to develop a flexible supply strategy to gain access to assembled and packaged drug delivery devices in clinical volumes without having to make substantial capital investment in facilities and equipment, while accelerating their timelines in moving forward with critical steps that are essential for completing clinical trial phases with their drug delivery devices.